Michael Grosse Appointed as New CEO of Sartorius AG

Michael Grosse will succeed Joachim Kreuzburg as Chief Executive Officer of Sartorius AG on July 1, 2025. The decision was made by the Supervisory Board following a thorough selection process initiated in the summer of 2024. Kreuzburg, who has been CEO for over two decades, announced he would not seek a contract renewal beyond its expiration in November 2025.

Sartorius' Chairman, Dr. Lothar Kappich, praised Kreuzburg's leadership, noting the company's significant growth under his tenure. He expressed confidence in Grosse's operational and strategic competencies, highlighting them as well-suited for Sartorius' culture.

Kreuzburg underscored Grosse's suitability and expressed commitment to ensuring continued innovative and profitable growth for Sartorius. Grosse, the incoming CEO, is eager to contribute to the biopharma sector alongside Sartorius' team.